ARCA biopharma, Inc.

The momentum for this stock is not very good. ARCA biopharma, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in ARCA biopharma, Inc..

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies f...

News

ARCA biopharma (NASDAQ:ABIO) Upgraded at StockNews.com

Zolmax StockNews.com upgraded shares of ARCA biopharma (NASDAQ:ABIO - Free Report) to a sell rating in a research report sent to investors on Tuesday.\nARCA biopharma Stock Performance\nARCA biopharma has a...\n more…

ARCA biopharma (NASDAQ:ABIO) Upgraded to Sell by StockNews.com

Ticker Report StockNews.com upgraded shares of ARCA biopharma (NASDAQ:ABIO - Free Report) to a sell rating in a research note published on Tuesday. ARCA biopharma Price Performance The firm has a market cap of...\n more…

ARCA biopharma, Inc. (NASDAQ:ABIO) Sees Significant Increase in Short Interest

Ticker Report ARCA biopharma, Inc. (NASDAQ:ABIO - Get Free Report) saw a significant growth in short interest during the month of August. As of August 15th, there was short interest totalling 4,990,000 shares, a...\n more…

ARCA biopharma, Inc. (NASDAQ:ABIO) Short Interest Update

Zolmax ARCA biopharma, Inc. (NASDAQ:ABIO - Get Free Report) saw a large growth in short interest in August. As of August 15th, there was short interest totalling 4,990,000 shares, a growth of 13.4% from...\n more…

ARCA biopharma (NASDAQ:ABIO) Shares Set to Reverse Split on Tuesday, September 3rd

Zolmax ARCA biopharma, Inc. (NASDAQ:ABIO - Free Report)'s stock is set to reverse split before the market opens on Tuesday, September 3rd. The 1-12 reverse split was announced on Friday, August 23rd. The...\n more…

ARCA Biopharma trading halted, news pending

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…